Executive Team


Alex Vodenlich, M.S.

President, Chief Executive Officer and Director

Mr. Vodenlich is a business executive with 30 years’ experience in startup and early-stage life science companies, specializing in fundraising, sales and business development, product commercialization, and general management. He was CEO of KromaTiD Inc., and president and CEO of Gentel Biosciences (Intuitive Biosciences). Mr. Vodenlich held other senior leadership roles at Lucigen (LGC Biosearch Technologies), Cellara LLC, and PanVera Corp. (Thermo Fisher Scientific). He holds bachelor’s and master’s degrees from the University of Wisconsin-Madison in medical microbiology and bacteriology.


Eric Schmuck, Ph.D.

Co-founder, Vice President and Chief Science Officer

Dr. Schmuck is the inventor of Cellular Logistics’ extracellular matrix technology and the company’s chief science officer, leading product development and operations. He also serves as director of translational research for the Dr. Amish Raval Laboratory at the UW-Madison. Dr. Schmuck’s research centers on therapies for cardiac regeneration, including a novel extracellular matrix generated in the lab that improves cardiac function. After its discovery, this material was licensed to the company by the Wisconsin Alumni Research Foundation. Dr. Schmuck earned his master’s degree and doctorate in human physiology from UW-Madison.


Zach Bower, M.S.

Business Development Associate

Mr. Bower assists the company with its business development efforts, including market identification and sizing, customer profiling and development, and market research. He has a strong understanding of the life science and medical device markets through his work with Medline Industries, UW-Health, Medtronic, Zimmer Biomet, and UW-Madison. Mr. Bower earned his bachelor’s and master’s degree in biomedical engineering with an emphasis in entrepreneurship from UW-Madison.

Board of Directors


Amish Raval, M.D.

Co-founder and Chairman of the Board

Dr. Raval is a co-founder of Cellular Logistics and is actively engaged in the company’s technology and product development strategies. He is a practicing interventional cardiologist who treats patients with advanced coronary artery, valve and vascular disease using transcatheter methods. He holds an appointment as an associate professor in the University of Wisconsin School of Medicine and Public Health where he is the director of clinical cardiovascular Research and the UW Heart Attack Program. He has served as national and site principal investigator on more than a dozen Phase I, II and III regenerative medicine trials for heart disease. Dr. Raval earned his medical degree from the University of Western Ontario, Canada, and has advanced clinical and research fellowship certification from Georgetown University, Washington Hospital Center, and the National Heart Lung and Blood Institute, National Institutes of Health in Bethesda.


Paul Resnick, M.D.


Dr. Resnick is an executive with broad leadership experience that spans large pharmaceutical and biotechnology companies, and encompasses corporate strategy, product development, licensing, mergers and acquisitions, and collaboration. He is chief business officer of Biolojic Design Inc., Boston, and previously held senior business development positions at Rinat Neuroscience Corp. (Pfizer), Pfizer Inc., Intellkine Inc. (Takeda), and Juventas Therapeutics Inc. He has demonstrated outstanding performance as a leader of business strategy that resulted in value creation and transformative partnerships. Dr. Resnick earned his medical degree from the Medical College of Wisconsin and a Master of Business Administration from the Wharton School of the University of Pennsylvania.


Alex Vodenlich, M.S.

President, Chief Executive Officer and Director

Scientific Advisory Board


Peiman Hematti, M.D.

Co-founder; Chair, Scientific Advisory Board

Dr. Hematti is professor of medicine, pediatrics, surgery, and biomedical engineering in the University of Wisconsin School of Medicine and Public Health. He is a hematopoietic stem cell transplant physician and serves as director of clinical hematopoietic cell processing laboratory, which collects and processes bone marrow and stem cells for transplantation at UW Health, academic medical center and health system for the University of Wisconsin. Dr. Hematti completed a combined internal medicine/pediatrics residency at the Cleveland Clinic Foundation and a clinical hematology and research fellowship at the National Heart, Lung, and Blood Institute of the National Institutes of Health. His clinical research interest is in the use of novel cellular immuno-therapies for hematological malignancies, including the use of cells produced in the bone marrow, specifically macrophages, in regenerative medicine. Dr. Hematti earned his medical degree at the Tehran University of Medical Sciences, Tehran, Iran.


Stephen Badylak, D.V.M., Ph.D., M.D.

Member, Scientific Advisory Board

Dr. Badylak is a professor in the department of surgery and deputy director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. More than 8 million patients have been treated with bio-scaffolds developed in Dr. Badylak’s laboratory. He holds numerous more than 60 U.S. patents and 300 patents worldwide. Dr. Badylak has authored more than 340 scientific publications and 40 book chapters. Dr. Badylak is a fellow of the American Institute for Medical and Biological Engineering, a member of the Society for Biomaterials, a charter member of the Tissue Engineering Society International, and a past president and founding international fellow of the Tissue Engineering Regenerative Medicine International Society. He earned his doctorate in anatomic pathology from Purdue University and his medical degree from Indiana University.


William Murphy, Ph.D.

Member, Scientific Advisory Board

Dr. Murphy is the Harvey D. Spangler professor of biomedical engineering, professor of orthopedics and rehabilitation, co-director of the Stem Cell and Regenerative Medicine Center, and director of the Human Models for Analysis of Pathways (MAPs) Center at UW-Madison. His research interests focus on creating new biomaterials inspired by the materials found in nature. Dr. Murphy’s research group is using new biomaterials to understand stem cell behavior and to induce tissue regeneration. He has published more than 150 scientific manuscripts, filed more 40 patents, co-founded multiple venture-backed startup companies, and received awards that include induction as a Fellow in the American Institute for Medical and Biological Engineering. Dr. Murphy earned his doctorate from the University of Michigan.


Nancy Sweitzer, M.D., Ph.D. 

Member, Scientific Advisory Board

Dr. Sweitzer is director of the University of Arizona Sarver Heart Center, professor of medicine and chief of the division of cardiology in the UA College of Medicine-Tucson. She is a board-certified advanced heart failure and transplant cardiologist and clinical researcher who is nationally recognized for her leadership and experience in clinical trials. She has done extensive work on the physiology of heart failure with preserved systolic function, a disease that disproportionately affects elderly women. She has led and collaborated on numerous studies sponsored by the National Institutes of Health, and by industry and academic sponsors. She serves as a member of the Clinical and Integrative Cardiovascular Science Study Section and the American Heart Association’s Cardiac Biology and Regulation Committee. Dr. Sweitzer earned her doctorate in physiology her medical degree from the UW-Madison.


Scott Fisher, Ph.D. 

Member, Scientific Advisory Board

Dr. Fisher is a product development expert with more than 20 years’ experience delivering clinical trial data in multiple therapeutic areas. He is a leader in the translation of therapies from concept to clinic, and a strong advocate for the advancement of regenerative medicine Scott is an executive- in-residence at BioEnterprise in Cleveland and the chief executive officer of CavoGene LifeSciences. Scott earned his bachelor’s degree at the University of Dayton, his master’s degree at Ohio State University and his doctorate at the University of Maryland, where he was an NIH pre-doctoral fellow. He was the first ever Rathmann Family Foundation post-doctoral fellow at the University of Maryland-Baltimore Office of Research and Development and the Baltimore Veterans’ Affairs Medical Center.